Abstract: The COVID-19 disease is prompted via the SARS-CoV-2 virus, which is highly infective within the human population. As there is no unique remedy for COVID-19 there is considerable Endeavour to elevate a vaccine towards SARS-CoV-2, in addition to engineering neutralizing antibody interventions. In the absence of a fantastic vaccine, movement controls of various stringencies have been imposed. The SARS-CoV-2 is a single stranded RNA virus, comprising three fundamental viral proteins; membrane, spike and envelope. The scientific features of COVID-19 sickness can be classified according to different tiers of severity, with some sufferers progressing to acute respiratory distress syndrome, which can be fatal. In addition, many infections are asymptomatic or solely cause moderate Symptoms. Conversely, different mutations of the virus, such as the Δ382 variant may want to decrease the medical relevance of infection. The front runners in the race to develop a fantastic vaccine centre of attention on the SARS-Co-V-2 spike protein. However, vaccines that produce a T-cell response to a wider range of SARS-Co-V-2 viral proteins may be extra effective. Population based research that determine the stage of innate immunity to SARS-CoV-2, from prior exposure to the virus or to different corona viruses, will have important implications for government imposed motion manage and the strategic delivery of vaccination programmers. To increase a nice vaccine focuses on the SARS-Co-V-2 spike protein. However, vaccines that produce a Tcell response to a wider vary of SARS-Co-V2 viral proteins, might also be greater effective. Vaccination programs purpose to manipulate the COVID-19 pandemic. However, the relative influences of vaccine coverage, effectiveness, and capacity in the context of non-pharmaceutical interventions such as mask use and bodily distancing on the spread of SARS-CoV-2 are unclear. In the experimentally determined SARS-CoV-derived B cell phone and T mobile phone epitopes in the immunogenic structural proteins of SARS-CoV, we recognized a set of B cell and T phone epitopes derived from the spike (S) and Nucleocapsid (N) proteins that map identically to SARS-CoV-2 proteins.